MX2016005263A - Composiciones activables para la liberacion controlada en dos etapas de sustancias quimicas proactivas. - Google Patents
Composiciones activables para la liberacion controlada en dos etapas de sustancias quimicas proactivas.Info
- Publication number
- MX2016005263A MX2016005263A MX2016005263A MX2016005263A MX2016005263A MX 2016005263 A MX2016005263 A MX 2016005263A MX 2016005263 A MX2016005263 A MX 2016005263A MX 2016005263 A MX2016005263 A MX 2016005263A MX 2016005263 A MX2016005263 A MX 2016005263A
- Authority
- MX
- Mexico
- Prior art keywords
- functional active
- triggerable
- stage
- controlled release
- release
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
- A61K8/8182—Copolymers of vinyl-pyrrolidones. Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L9/00—Disinfection, sterilisation or deodorisation of air
- A61L9/01—Deodorant compositions
- A61L9/012—Deodorant compositions characterised by being in a special form, e.g. gels, emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q13/00—Formulations or additives for perfume preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B9/00—Essential oils; Perfumes
- C11B9/0007—Aliphatic compounds
- C11B9/0015—Aliphatic compounds containing oxygen as the only heteroatom
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B9/00—Essential oils; Perfumes
- C11B9/0026—Essential oils; Perfumes compounds containing an alicyclic ring not condensed with another ring
- C11B9/003—Essential oils; Perfumes compounds containing an alicyclic ring not condensed with another ring the ring containing less than six carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B9/00—Essential oils; Perfumes
- C11B9/0061—Essential oils; Perfumes compounds containing a six-membered aromatic ring not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/54—Polymers characterized by specific structures/properties
- A61K2800/548—Associative polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Abstract
Una composición activable para la liberación controlada en dos etapas de una sustancia química activa funcional incluye un éster de trigonelina de una sustancia activa funcional con al menos un grupo hidroxilo que se configura para liberar la sustancia activa funcional a través de una reacción de hidrólisis tras el contacto con un medio acuoso, y un material de encapsulación para encapsular el éster de trigonelina que incluye una sustancia activa funcional, el material de encapsulación es activable para liberar el éster de trigonelina tras la ocurrencia de un estímulo ambiental. En otros aspectos, un líquido viscoso o un artículo absorbente incluye una composición activable para la liberación controlada en dos etapas de una sustancia química activa funcional, la composición incluye un éster de trigonelina de una sustancia activa funcional con al menos un grupo hidroxilo que se configura para liberar la sustancia activa funcional a través de una reacción de hidrólisis tras el contacto con un medio acuoso, y un material de encapsulación para encapsular el éster de trigonelina que incluye una sustancia activa funcional.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/066,856 US9119780B2 (en) | 2013-10-30 | 2013-10-30 | Triggerable compositions for two-stage, controlled release of proactive chemistry |
PCT/IB2014/065311 WO2015063638A1 (en) | 2013-10-30 | 2014-10-14 | Triggerable compositions for two-stage, controlled release of proactive chemistry |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2016005263A true MX2016005263A (es) | 2016-08-18 |
MX353460B MX353460B (es) | 2018-01-12 |
Family
ID=52995728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016005263A MX353460B (es) | 2013-10-30 | 2014-10-14 | Composiciones activables para la liberación controlada en dos etapas de sustancias químicas proactivas. |
Country Status (7)
Country | Link |
---|---|
US (1) | US9119780B2 (es) |
KR (1) | KR101732326B1 (es) |
AU (1) | AU2014343312B2 (es) |
BR (1) | BR112016009187B1 (es) |
GB (1) | GB2535098B (es) |
MX (1) | MX353460B (es) |
WO (1) | WO2015063638A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019508505A (ja) * | 2016-03-14 | 2019-03-28 | スフェラ ファーマ ピーブイティー リミテッドSphaera Pharma Pvt. Ltd. | トリゴネリンベースの化合物 |
Family Cites Families (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4020156A (en) | 1976-02-13 | 1977-04-26 | Norda Incorporated | Controlled fragrance releasing crystal beads |
US4880921A (en) | 1982-05-18 | 1989-11-14 | University Of Florida | Brain-specific drug delivery |
US4540564A (en) | 1982-05-18 | 1985-09-10 | University Of Florida | Brain-specific drug delivery |
JP2775154B2 (ja) | 1988-04-26 | 1998-07-16 | 株式会社資生堂 | 肌荒れ防止剤および老化防止剤 |
US5130290A (en) | 1989-03-27 | 1992-07-14 | Kanzaki Paper Manufacturing Co., Ltd. | Water-sensitive coloring sheet |
US5133958A (en) | 1989-04-20 | 1992-07-28 | Erwin Stuckler | Agent for nail, skin and hair care |
JPH03221039A (ja) | 1990-01-26 | 1991-09-30 | Kanzaki Paper Mfg Co Ltd | 紙おむつ |
US5197958A (en) | 1992-04-01 | 1993-03-30 | Howell Wesley A | Wetness indicating diaper |
US5622944A (en) | 1992-06-12 | 1997-04-22 | Affymax Technologies N.V. | Testosterone prodrugs for improved drug delivery |
EP0752465A1 (en) | 1995-06-01 | 1997-01-08 | The Procter & Gamble Company | Betaine esters for delivery of alcohols |
PT771785E (pt) | 1995-11-02 | 2002-06-28 | Procter & Gamble | Compostos aminoester de alcoois perfumados e seu uso em composicoes de limpeza ou lavandaria |
US5958870A (en) | 1996-04-01 | 1999-09-28 | The Procter & Gamble Company | Betaine ester compounds of active alcohols |
AU739247B2 (en) | 1996-12-17 | 2001-10-04 | Procter & Gamble Company, The | Absorbent articles with odor control system |
US5827913A (en) | 1997-02-05 | 1998-10-27 | H.B. Fuller Licensing & Financing, Inc. | Hot melt adhesive comprising an encapsulated ingredient |
DE19818044A1 (de) | 1998-04-22 | 1999-10-28 | Klinge Co Chem Pharm Fab | Verwendung von Vitamin-PP-Verbindungen |
AU4025800A (en) | 1999-03-22 | 2000-10-09 | Ideation International, Inc. | Composite fiber for absorptive material construction |
DE19948667A1 (de) | 1999-10-08 | 2001-04-12 | Henkel Kgaa | Reinigungsmittelkomponente mit doppelkontrollierter Duftfreisetzung |
WO2001028980A1 (fr) | 1999-10-18 | 2001-04-26 | Firmenich S.A. | Esters comportant une fonction carbamoyle secondaire et leur utilisation en tant que precurseurs d'alcools odorants |
JP3853549B2 (ja) | 1999-11-10 | 2006-12-06 | 花王株式会社 | 機能性アルコール放出物質 |
US6369290B1 (en) | 2000-02-17 | 2002-04-09 | Tyco Healthcare Retail Services Ag | Time release odor control composition for a disposable absorbent article |
US7758888B2 (en) | 2000-04-21 | 2010-07-20 | Sol-Gel Technologies Ltd. | Composition exhibiting enhanced formulation stability and delivery of topical active ingredients |
WO2001085081A1 (en) | 2000-05-09 | 2001-11-15 | The Procter & Gamble Company | Composite fabric panel for disposable absorbent articles |
EP1203578A1 (en) * | 2000-11-03 | 2002-05-08 | The Procter & Gamble Company | Methods and compositions for improved fragrancing of a surface |
WO2003047558A2 (en) | 2001-12-03 | 2003-06-12 | Genset S.A. | Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase inhibitors |
DE10217705A1 (de) | 2002-04-20 | 2003-11-06 | Goldschmidt Ag Th | Wäscheweichspülformulierungen enthaltend Betainesterderivate sowie Verfahren zur Verbesserung der Waschleistung von Waschmitteln |
EP1521571A1 (en) | 2002-07-04 | 2005-04-13 | Janssen Pharmaceutica N.V. | Solid dispersion comprising two different polymer matrixes |
US7670627B2 (en) | 2002-12-09 | 2010-03-02 | Salvona Ip Llc | pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients |
EP1428867B1 (en) | 2002-12-09 | 2007-08-01 | Rohm And Haas Company | Multi-stage polymer compositions having a triggered response |
US8409618B2 (en) | 2002-12-20 | 2013-04-02 | Kimberly-Clark Worldwide, Inc. | Odor-reducing quinone compounds |
ES2278314T3 (es) | 2003-04-17 | 2007-08-01 | Jallal Messadek | Formulaciones orales para la liberacion controlada de la betaina. |
WO2004098555A1 (de) | 2003-05-07 | 2004-11-18 | Ifac Gmbh & Co.Kg | Zusammensetzungen zur gezielten freisetzung von duftstoffen und aromen |
SE0302924D0 (sv) | 2003-11-05 | 2003-11-05 | Camurus Ab | Pharmaceutical composition having a cationic excipient |
DE102004013798A1 (de) | 2004-03-20 | 2005-10-06 | Wella Aktiengesellschaft | Verwendung von Mitteln zur kosmetischen Behandlung von Keratin enthaltenden Material |
ES2368062T3 (es) | 2004-04-30 | 2011-11-14 | The Procter & Gamble Company | Artículo absorbente que cambia de color. |
EP1624002B1 (en) | 2004-08-07 | 2019-04-03 | The Procter & Gamble Company | Superabsorbent polymer particles comprising functionalizers and method of making them |
FR2880884B1 (fr) | 2005-01-19 | 2007-04-20 | Mane Fils Sa V | Nouveaux composes odorants, procede de synthese et utilisations |
WO2006131430A1 (de) | 2005-06-09 | 2006-12-14 | Evonik Degussa Gmbh | Riechstoffalkohol freisetzendes polysiloxan |
CN101277727B (zh) | 2005-10-05 | 2014-04-16 | Sca卫生用品公司 | 包括含活化剂薄膜的吸收性制品 |
US20070105793A1 (en) | 2005-11-04 | 2007-05-10 | Curt Hendrix | Compositions and methods using nicotinic acid for treatment of hypercholesterolemia, hyperlipidemia nd cardiovascular disease |
US20070270773A1 (en) | 2006-05-16 | 2007-11-22 | Suzan Delain Mackey | Absorbent articles and garments with thermochromic wetness indicator(s) |
WO2008037076A1 (en) | 2006-09-27 | 2008-04-03 | Luvgear Inc. | Device and method for identifying a change in a predetermined condition |
ATE501179T1 (de) | 2006-10-10 | 2011-03-15 | Firmenich & Cie | Polymerkonjugate zur kontrollierten freigabe von aktiven molekülen |
EP2081474A4 (en) | 2006-10-20 | 2011-03-09 | Nestec Sa | WASTE COLLECTION MAT |
US20080139378A1 (en) | 2006-12-07 | 2008-06-12 | Degussa Ag | Urine-absorbing composition with fragrance release upon use |
CA2679206C (en) | 2007-03-05 | 2015-02-24 | Indus Biotech Private Limited | Pharmaceutical compositions comprising trigonelline and 4-hydroxyisoleucine and a process thereof |
US8029190B2 (en) | 2007-05-10 | 2011-10-04 | Kimberly-Clark Worldwide, Inc. | Method and articles for sensing relative temperature |
EP1992366B1 (en) | 2007-05-15 | 2011-07-06 | The Procter & Gamble Company | Use of a lotion composition on an absorbent article for reducing adherence of feces or menses to the skin |
US7550416B2 (en) | 2007-06-27 | 2009-06-23 | The Procter & Gamble Company | Perfumed household products and methods for preserving perfume integrity and extending fragrance life |
WO2009018368A1 (en) | 2007-07-30 | 2009-02-05 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Combination treatment of nmda (n-methyl-d-aspartate)-enhancer, glycine transporter inhibitor, d-amino acid oxidase inhibitor (daaoi) for neuropsychiatric disorders |
WO2009028118A1 (ja) | 2007-08-29 | 2009-03-05 | Nippon Paper Industries Co., Ltd. | 感熱記録体 |
US20090156634A1 (en) | 2007-12-12 | 2009-06-18 | Iovate T. & P. Inc. | Tropane alkaloids and trigonelline combinations and methods for administering the same |
US8497409B2 (en) | 2008-02-29 | 2013-07-30 | Kimberly-Clark Worldwide, Inc. | Absorbent article having an olfactory wetness signal |
US20110046571A1 (en) | 2008-04-15 | 2011-02-24 | Waldhorn Joshua | Absorbing and Saturation Detection Pad and Methods Thereof |
US20090275908A1 (en) | 2008-04-30 | 2009-11-05 | Kimberly-Clark Worldwide, Inc. | Absorbent Articles Capable of Indicating the Presence of Urine |
WO2009157395A1 (ja) | 2008-06-25 | 2009-12-30 | 共同印刷株式会社 | 湿度インジケータとその製造方法 |
US9554948B2 (en) | 2008-07-30 | 2017-01-31 | Kimberly-Clark Worldwide, Inc. | Absorbent products with wetness sensors |
TWI404544B (zh) | 2008-08-11 | 2013-08-11 | Colgate Palmolive Co | 含珠粒之口腔保健組成物 |
US8889635B2 (en) | 2008-09-30 | 2014-11-18 | The Regents Of The University Of Michigan | Dendrimer conjugates |
US20100191205A1 (en) | 2009-01-29 | 2010-07-29 | Sca Hygiene Products Ab | Opening system for absorbent articles |
PL2440206T3 (pl) | 2009-06-11 | 2018-12-31 | Dsm Ip Assets B.V. | Trygonelina jako stymulator mięśni |
US9265856B2 (en) | 2009-07-15 | 2016-02-23 | Kimberly-Clark Worldwide Inc. | Multiple component materials having a color-changing composition |
EP2488172A4 (en) | 2009-10-13 | 2014-08-13 | Univ Michigan | DENDRIMER COMPOSITION AND METHOD FOR THEIR SYNTHESIS |
US8697003B2 (en) | 2009-12-14 | 2014-04-15 | Kimberly-Clark Worldwide, Inc. | Aqueous-triggered color-appearing inks |
US8557894B2 (en) | 2009-12-17 | 2013-10-15 | Kimberly-Clark Worldwide, Inc. | Water-triggered coloring or color changing indicator |
EP2588089B1 (en) | 2010-04-07 | 2017-08-30 | Kemin Industries, Inc. | Micro particles for oral delivery in animals |
US20120064136A1 (en) | 2010-09-10 | 2012-03-15 | Nanobio Corporation | Anti-aging and wrinkle treatment methods using nanoemulsion compositions |
US20120177730A1 (en) | 2011-01-07 | 2012-07-12 | Elcelyx Therapeutics, Inc. | Chemosensory Receptor Ligand-Based Therapies |
WO2013016257A1 (en) | 2011-07-25 | 2013-01-31 | Us Cosmeceu Techs Llc | Botanical antioxidant compositions and methods of preparation and use thereof |
US8791045B2 (en) * | 2011-11-09 | 2014-07-29 | Kimberly-Clark Worldwide, Inc. | Non-tacky wetness indicator composition for application on a polymeric substrate |
-
2013
- 2013-10-30 US US14/066,856 patent/US9119780B2/en active Active
-
2014
- 2014-10-14 MX MX2016005263A patent/MX353460B/es active IP Right Grant
- 2014-10-14 KR KR1020167012084A patent/KR101732326B1/ko active IP Right Grant
- 2014-10-14 GB GB1609169.6A patent/GB2535098B/en active Active
- 2014-10-14 AU AU2014343312A patent/AU2014343312B2/en active Active
- 2014-10-14 WO PCT/IB2014/065311 patent/WO2015063638A1/en active Application Filing
- 2014-10-14 BR BR112016009187-6A patent/BR112016009187B1/pt active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
BR112016009187B1 (pt) | 2020-11-03 |
GB2535098A (en) | 2016-08-10 |
MX353460B (es) | 2018-01-12 |
WO2015063638A1 (en) | 2015-05-07 |
AU2014343312B2 (en) | 2017-11-09 |
GB201609169D0 (en) | 2016-07-06 |
US20150118294A1 (en) | 2015-04-30 |
KR101732326B1 (ko) | 2017-05-02 |
GB2535098B (en) | 2020-09-23 |
KR20160070101A (ko) | 2016-06-17 |
AU2014343312A1 (en) | 2016-06-02 |
US9119780B2 (en) | 2015-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2863681A1 (en) | Topical use of a skin-commensal prebiotic agent and compositions containing the same | |
WO2013103832A3 (en) | Personal care compositions containing ionic silicone and film-forming agent | |
MX2015005207A (es) | Material polimerico para un recipiente aislado. | |
FR3010900B1 (fr) | Composition cosmetique comprenant une association d'agents tensioactifs de types carboxylate, acyl-isethionate, et alkyl(poly)glycoside. | |
GB2508777A (en) | Polymeric material for an insulated container | |
SI2958913T1 (sl) | Sfingozin-1-fosfat receptor agonisti, postopki za njegovo pripravo in farmacevtski sestavki, ki ga vsebujejo kot aktivno sredstvo | |
WO2012087823A3 (en) | Ph-induced silk fibroin gels and uses thereof | |
FR2998570B1 (fr) | Peptides, compositions les comprenant et utilisations notamment cosmetiques propigmentantes | |
MX2016016984A (es) | Material de interconexion termica con depurador ionico. | |
NZ619857A (en) | A fast dissolving pharmaceutical composition | |
MX2016007067A (es) | Microcapsulas lipidicas que comprenden de preferencia un retinoide y composicion que las contiene, su procedimiento de preparacion y su uso en dermatologia. | |
MX2017006148A (es) | Composiciones para el cuidado personal con dos fases beneficas. | |
MX2016005395A (es) | Formulacion estable de insulina glulisina. | |
MY180353A (en) | Oral composition | |
MX348807B (es) | Composiciones activables para la liberacion controlada en dos etapas de sustancias quimicas activas. | |
CL2015001748A1 (es) | Formulaciones antiparasitarias transdermicas | |
MX359713B (es) | Composiciones mejoradas para la cicatrizacion de heridas que comprenden microesferas. | |
GB2535098A (en) | Triggerable compositions for two-stage, controlled release of proactive chemistry | |
MX2015016490A (es) | Esteres sulfatados de acidos oligohidroxicarboxilicos, y uso de los mismos. | |
PH12014501307A1 (en) | Liquid activation system | |
WO2013107687A3 (fr) | Compositions dermo-cosmétiques à base d'une association synergique d'argent colloïdal et d'acide désoxyribonucléique | |
PH12019502645A1 (en) | Non-reversible humidity indicator card | |
WO2012154802A3 (en) | Compositions for reducing particulates in the air | |
MX2016010945A (es) | Composiciones activables para la liberacion controlada en dos etapas, de compuestos quimicos proactivos que usan aldehidos. | |
MX2013006735A (es) | Pildora viscosa polimerica activada y metodos de uso de la misma. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |